Document:

EXHIBIT
      10.2

    

     

    "THESE
      SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
      (THE "ACT"), AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISTRIBUTED, DIRECTLY
      OR INDIRECTLY, IN THE UNITED STATES, ITS TERRITORIES, POSSESSIONS, OR AREAS
      SUBJECT TO ITS JURISDICTION, OR TO OR FOR THE ACCOUNT OR BENEFIT OF A "U.S.
      PERSON" AS THAT TERM IS DEFINED IN RULE 902 OR REGULATION S OF THE ACT, AT
      ANY
      TIME PRIOR TO ONE (1) YEAR AFTER THE ISSUANCE OF THIS CERTIFICATE, IN THE
      ABSENCE OF (i) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER
      THE
      ACT, OR (ii) AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT
      SUCH REGISTRATION IS NOT REQUIRED PURSUANT TO A VALID EXEMPTION THEREFROM FROM
      UNDER THE ACT. HEDGING TRANSACTIONS INVOLVING THE SHARES REPRESENTED HEREBY
      MAY
      NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE ACT. ANY SALES, TRANSFERS OR
      OTHER DISTRIBUTIONS OF THE SECURITIES MUST BE MADE IN ACCORDANCE WITH THE
      PROVISIONS OF REGULATION S OF THE ACT. THIS CERTIFICATE MUST BE SURRENDERED
      TO
      THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, TRANSFER
      OR OTHER DISTRIBUTION OF ANY INTEREST IN ANY OF THE SECURITIES REPRESENTED
      BY
      THIS CERTIFICATE."

     

    Warrant
      No. 242

     

    WARRANT
      TO PURCHASE SHARES OF COMMON STOCK

     

    OF

     

    NEOSTEM,
      INC.

     

    THIS
      CERTIFIES that, for value received, RimAsia Capital Partners, L.P. is entitled
      to purchase from NEOSTEM, INC., a Delaware corporation (the “Corporation”),
      subject to the terms and conditions hereof, one million (1,000,000) shares
      (the
“Warrant
      Shares”)
      of
      common stock, $.001 par value (the “Common
      Stock”).
      This
      warrant, together with all warrants hereafter issued in exchange or substitution
      for this warrant, is referred to as the “Warrant”
and
      the
      holder of this Warrant is referred to as the “Holder.”
The
      number of Warrant Shares is subject to adjustment as hereinafter provided.
      Notwithstanding anything to the contrary contained herein, this Warrant shall
      expire at 5:00 p.m. (Eastern Time) on September 1, 2013 (the “Termination
      Date”).
      

     

    1. Exercise
      of Warrant.
      The
      Holder may, at any time six months after the date of issuance and prior to
      the
      Termination Date, exercise this Warrant in whole or in part at an exercise
      price
      per share equal to $1.75 per share, subject to adjustment as provided herein
      (the “Exercise
      Price”),
      by
      the surrender of this Warrant (properly endorsed) at the principal office of
      the
      Corporation, or at such other agency or office of the Corporation in the United
      States of America as the Corporation may designate by notice in writing to
      the
      Holder at the address of such Holder appearing on the books of the Corporation,
      and by payment to the Corporation of the Exercise Price in lawful money of
      the
      United States by check or wire transfer for each share of Common Stock being
      purchased. Upon any partial exercise of this Warrant, there shall be executed
      and issued to the Holder a new Warrant in respect of the shares of Common Stock
      as to which this Warrant shall not have been exercised. In the event of the
      exercise of the rights represented by this Warrant, a certificate or
      certificates for the Warrant Shares so purchased, as applicable, registered
      in
      the name of the Holder, shall be delivered to the Holder hereof as soon as
      practicable after the rights represented by this Warrant shall have been so
      exercised. The Holder acknowledges that the Holder shall not be entitled to
      exercise the Warrant unless it provides the Corporation with: (1) written
      certification that the Holder is not a U.S. Person (within the meaning of
      Regulation S ("Regulation
      S")
      promulgated under the Securities Act of 1933, as amended (the "Securities
      Act"))
      and
      the Warrant is not being exercised on behalf of a U.S. Person; or (2) a written
      opinion of counsel, satisfactory to the Corporation, to the effect that the
      Warrant and the Warrant Shares delivered upon exercise hereof have been
      registered under the Securities Act or are exempt from registration thereunder.
      Without limiting the foregoing, the Holder further acknowledges that the Holder
      shall not be entitled to exercise the Warrant unless it provides the Corporation
      with a written opinion of counsel, satisfactory to the Corporation, to the
      effect that (a) the Warrant is not being exercised within the United States
      (within the meaning of Regulation S), and the Warrant Shares are not being
      delivered within the United States other than in an offering deemed to meet
      the
      definition of "offshore transaction" pursuant to Rule 902(h) of Regulation
      S, or
      (b) the Warrant and the Warrant Shares are registered under the Act or an
      exemption from such registration is available. 

    

    
      
         

      

      
        -
          1
          -

        
          

        

      

      
         

      

    

    2. Reservation
      of Warrant Shares.
      The
      Corporation agrees that, prior to the expiration of this Warrant, it will at
      all
      times have authorized and in reserve, and will keep available, solely for
      issuance or delivery upon the exercise of this Warrant, the number of Warrant
      Shares as from time to time shall be issuable by the Corporation upon the
      exercise of this Warrant.

     

    3. No
      Stockholder Rights; No Rights to Net Cash Settle.
      This
      Warrant shall not entitle the holder hereof to any voting rights or other rights
      as a stockholder of the Corporation. In no event may this Warrant be net cash
      settled.

     

    4. Transferability
      of Warrant.
      Prior
      to the Termination Date and subject to compliance with applicable Federal and
      State securities and other laws, this Warrant and all rights hereunder are
      transferable, in whole or in part, at the office or agency of the Company by
      the
      Holder in person or by duly authorized attorney, upon surrender of this Warrant
      together with the Assignment Form annexed hereto properly endorsed for transfer.
      Any registration rights to which this Warrant may then be subject shall be
      transferred together with the Warrant to the subsequent Investor.

     

    5. Certain
      Adjustments.
      With
      respect to any rights that Holder has to exercise this Warrant and convert
      into
      shares of Common Stock, Holder shall be entitled to the following
      adjustments:

     

    (a) Merger
      or Consolidation.
      If at
      any time there shall be a merger or a consolidation of the Corporation with
      or
      into another entity when the Corporation is not the surviving corporation,
      then,
      as part of such merger or consolidation, lawful provision shall be made so
      that
      the holder hereof shall thereafter be entitled to receive upon exercise of
      this
      Warrant, during the period specified herein and upon payment of the aggregate
      Exercise Price then in effect, the number of shares of stock or other securities
      or property (including cash) of the successor corporation resulting from such
      merger or consolidation, to which the holder hereof as the holder of the stock
      deliverable upon exercise of this Warrant would have been entitled in such
      merger or consolidation if this Warrant had been exercised immediately before
      such transaction. In any such case, appropriate adjustment shall be made in
      the
      application of the provisions of this Warrant with respect to the rights and
      interests of the holder hereof as the holder of this Warrant after the merger
      or
      consolidation.

     

    (b) Reclassification,
      Recapitalization, etc.
      If the
      Corporation at any time shall, by subdivision, combination or reclassification
      of securities, recapitalization, automatic conversion, or other similar event
      affecting the number or character of outstanding shares of Common Stock, or
      otherwise, change any of the securities as to which purchase rights under this
      Warrant exist into the same or a different number of securities of any other
      class or classes, this Warrant shall thereafter represent the right to acquire
      such number and kind of securities as would have been issuable as the result
      of
      such change with respect to the securities that were subject to the purchase
      rights under this Warrant immediately prior to such subdivision, combination,
      reclassification or other change.

     

    (c) Split
      or Combination of Common Stock and Stock Dividend.
      In case
      the Corporation shall at any time subdivide, redivide, recapitalize, split
      (forward or reverse) or change its outstanding shares of Common Stock into
      a
      greater number of shares or declare a dividend upon its Common Stock payable
      solely in shares of Common Stock, the Exercise
      Price
      shall be
      proportionately reduced and the number of Warrant Shares proportionately
      increased. Conversely, in case the outstanding shares of Common Stock of the
      Corporation shall be combined into a smaller number of shares, the Exercise
      Price
      shall be
      proportionately increased and the number of Warrant Shares proportionately
      reduced.

     

    
      
         

      

      
        -
          2
          -

        
          

        

      

      
         

      

    

    6. Legend
      and Stop Transfer Orders.
      Unless
      the Warrant Shares have been registered under the Securities Act, upon exercise
      of any part of the Warrant, the Corporation shall instruct its transfer agent
      to
      enter stop transfer orders with respect to such Warrant Shares, and all
      certificates or instruments representing the Warrant Shares shall bear on the
      face thereof substantially the following legend:

     

     

    "THESE
      SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
      (THE "ACT"), AND MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISTRIBUTED, DIRECTLY
      OR INDIRECTLY, IN THE UNITED STATES, ITS TERRITORIES, POSSESSIONS, OR AREAS
      SUBJECT TO ITS JURISDICTION, OR TO OR FOR THE ACCOUNT OR BENEFIT OF A "U.S.
      PERSON" AS THAT TERM IS DEFINED IN RULE 902 OR REGULATION S OF THE ACT, AT
      ANY
      TIME PRIOR TO ONE (1) YEAR AFTER THE ISSUANCE OF THIS CERTIFICATE, IN THE
      ABSENCE OF (i) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER
      THE
      ACT, OR (ii) AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT
      SUCH REGISTRATION IS NOT REQUIRED PURSUANT TO A VALID EXEMPTION THEREFROM FROM
      UNDER THE ACT. HEDGING TRANSACTIONS INVOLVING THE SHARES REPRESENTED HEREBY
      MAY
      NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE ACT. ANY SALES, TRANSFERS OR
      OTHER DISTRIBUTIONS OF THE SECURITIES MUST BE MADE IN ACCORDANCE WITH THE
      PROVISIONS OF REGULATION S OF THE ACT. THIS CERTIFICATE MUST BE SURRENDERED
      TO
      THE COMPANY OR ITS TRANSFER AGENT AS A CONDITION PRECEDENT TO THE SALE, TRANSFER
      OR OTHER DISTRIBUTION OF ANY INTEREST IN ANY OF THE SECURITIES REPRESENTED
      BY
      THIS CERTIFICATE."

     

    7.
      Redemption
      of Warrant.
      This
      Warrant is subject to redemption by the Company as provided in this Section
      7.

     

    (a) Commencing
      six months after the date of this Warrant, this Warrant may be redeemed, at
      the
      option of the Company, in whole and not in part, at a redemption price of $.0001
      per Warrant (the “Redemption
      Price”),
      provided (i) the average closing price of the Common Stock as quoted by
      Bloomberg, LP., or the Principal Trading Market (as defined below) on which
      the
      Common Stock is included for quotation or trading, shall equal or exceed $3.50
      per share (taking into account all adjustments) for twenty (20) out of thirty
      (30) consecutive trading days, and (ii) the dollar value of the trading volume
      of the Common Stock for each day during the twenty (20) out of thirty (30)
      consecutive trading days equals or exceeds $100,000. 

     

    (b) If
      the
      conditions set forth in Section
      7(a)
      are met,
      and the Company desires to exercise its right to redeem this Warrant, it shall
      mail a notice (the “Redemption
      Notice”)
      to the
      registered holder of this Warrant by first class mail, postage prepaid, at
      least
      ten (10) business days prior to the date fixed by the Company for redemption
      of
      the Warrants (the “Redemption
      Date”).

     

    (c
      ) The
      Redemption Notice shall specify (i) the Redemption Price, (ii) the Redemption
      Date, (iii) the place where the Warrant certificates shall be delivered and
      the
      redemption price paid, and (iv) that the right to exercise this Warrant shall
      terminate at 5:00 p.m. (New York time) on the business day immediately
      preceding the Redemption Date. No failure to mail such notice nor any defect
      therein or in the mailing thereof shall affect the validity of the proceedings
      for such redemption except as to a holder (a) to whom notice was not mailed,
      or
      (b) whose notice was defective. An affidavit of the Secretary or an
      Assistant Secretary of the Company that the Redemption Notice has been mailed
      shall, in the absence of fraud, be prima
      facie
      evidence
      of the facts stated therein.

     

    
      
         

      

      
        -
          3
          -

        
          

        

      

      
         

      

    

    (d) Any
      right
      to exercise a Warrant shall terminate at 5:00 p.m. (New York time) on the
      business day immediately preceding the Redemption Date. On and after the
      Redemption Date, the holder of this Warrant shall have no further rights except
      to receive, upon surrender of this Warrant, the Redemption Price.

     

    (e) From
      and
      after the Redemption Date, the Company shall, at the place specified in the
      Redemption Notice, upon presentation and surrender to the Company by or on
      behalf of the holder thereof the warrant certificates evidencing this Warrant
      being redeemed, deliver, or cause to be delivered to or upon the written order
      of such holder, a sum in cash equal to the Redemption Price of this Warrant.
      From and after the Redemption Date, this Warrant shall expire and become void
      and all rights hereunder and under the warrant certificates, except the right
      to
      receive payment of the Redemption Price, shall cease. 

     

    8. Miscellaneous.
      This
      Warrant shall be governed by and construed in accordance with the laws of the
      State of Delaware. All the covenants and provisions of this Warrant by or for
      the benefit of the Corporation shall bind and inure to the benefit of its
      successors and assigns hereunder. Nothing in this Warrant shall be construed
      to
      give to any person or corporation other than the Corporation and the holder
      of
      this Warrant any legal or equitable right, remedy, or claim under this Warrant.
      This Warrant shall be for the sole and exclusive benefit of the Corporation
      and
      the Holder. The section headings herein are for convenience only and are not
      part of this Warrant and shall not affect the interpretation hereof. Upon
      receipt of evidence satisfactory to the Corporation of the loss, theft,
      destruction, or mutilation of this Warrant, and of indemnity reasonably
      satisfactory to the Corporation, if lost, stolen, or destroyed, and upon
      surrender and cancellation of this Warrant, if mutilated, the Corporation shall
      execute and deliver to the Holder a new Warrant of like date, tenor, and
      denomination.

     

    

    
      
         

      

      
        -
          4
          -

        
          

        

      

      
         

      

    

     

    IN
      WITNESS WHEREOF, the Corporation has caused this Warrant to be executed by
      its
      duly authorized officers under its seal, this ___ day of ________
      2008.

    

      
        	 	
                NEOSTEM,
                  INC.

              
	 	 
	 	 
	 	   

	 	
                Robin
                  L. Smith, Chairman & Chief Executive
                  Officer

              

      

    
      
         

      

      
        -
          5
          -

        
          

        

      

      
         

      

    

    WARRANT
      EXERCISE FORM

     

    To
      Be Executed by the Holder in Order to Exercise Warrant

     

    
      	To: 	
              NeoStem,
                Inc.

              
                420
                  Lexington Avenue

                Suite
                  450

                New
                  York, New York 10170

                Attn:
                  Chairman and CEO

              

            	
              Dated:
                ____________ __, 20__

            

    

     

    The
      undersigned, pursuant to the provisions set forth in the attached Warrant
      No. ______, hereby irrevocably elects to purchase ____________ shares of
      the Common Stock of NeoStem, Inc. covered by such Warrant.

     

    
      	 	
               ̈

            	
              The
                undersigned herewith makes payment of the full purchase price for
                such
                shares at the price per share provided for in such Warrant. Such
                payment
                takes the form of $__________ in lawful money of the United
                States.

            

    

     

    The
      undersigned hereby requests that certificates for the Warrant Shares purchased
      hereby be issued in the name of:

     

    
      	   
	 
	   
	 
	
              (please
                print or type name and address)

            	 
	   
	 
	
              (please
                insert social security or other identifying number)

            	 
	
              and
                be delivered as follows:

            	 
	 	 
	   
	 
	
              (please
                print or type name and address)

            	 
	   
	 
	
              (please
                insert social security or other identifying number)

            	 

    

     

    and
      if
      such number of shares of Common Stock shall not be all the shares evidenced
      by
      this Warrant Certificate, that a new Warrant for the balance of such shares
      be
      registered in the name of, and delivered to, Holder.

     

    

    
      	 	   

	 	
              Signature
                of Holder

            
	 	 
	 	
              SIGNATURE
                GUARANTEE:

            
	 	 
	 	   
 

    

    
      
         

      

      
        -
          6
          -

        
          

        

      

      
         

      

    

    ASSIGNMENT
      FORM

    

    (To
      assign the foregoing warrant, execute

    this
      form. Do not use this form to exercise the warrant.)

     

    
 

    FOR
      VALUE
      RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby
      assigned to

     

     

    
      
        

      

    

     

    whose
      address is

    

     

      
        

      

    

    

     

      
        

      

    

    

    

    Dated:
      ________ __, 20___

    

    

    
      	 	
              Holder’s
                Signature:

            	  

	 	
              Holder’s
                Address:

            	   

	 	 	   

    

    
 

    

    Signature
      Guaranteed:    _________________________________

    

    
 

    NOTE:
      The
      signature to this Assignment Form must correspond with the name as it appears
      on
      the face of the Warrant, without alteration or enlargement or any change
      whatsoever, and must be guaranteed by a bank or trust Corporation. Officers
      of
      corporations and those acting in a fiduciary or other representative capacity
      should file proper evidence of authority to assign the foregoing
      Warrant.

    
 

    
      
         

      

      
        -
          7
          -Unassociated Document

    SECURITIES
      PURCHASE AGREEMENT 

     

    THIS
      SECURITIES PURCHASE AGREEMENT (this "Agreement")
      is made
      and entered into as of the 3rd day of September, 2008 (the “Effective
      Date”)
      by and
      among BioAuthorize Holdings, Inc. formerly known as Genesis Holdings, Inc.,
      a
      Nevada corporation (“Company”),
      and
      Launch Pad Research and Marketing Company, an Arizona corporation (“Launch”).
      

    

    RECITALS

    

     

    A. Subject
      to the terms and conditions set forth in this Agreement and pursuant to Section
      4(2) of the Securities Act of 1933, as amended (the “Securities
      Act”),
      and
      Rule 506 promulgated thereunder, the Company desires to issue and sell to
      Launch, and Launch desires to purchase from the Company, securities of the
      Company as more fully described in this Agreement. 

     

    AGREEMENT

     

    NOW,
      THEREFORE, in consideration of the premises, the mutual representations,
      warranties, covenants, conditions and agreements contained herein, and for
      other
      good and valuable consideration, the receipt and sufficiency of which are hereby
      acknowledged, the Company and Launch (each a “Party”
      and
      collectively, the "Parties")
      hereby
      agree as follows:

    

    SECTION
      1

    

    PURCHASE
      AND SALE

    

    1.1 Purchase
      and Sale. 

     

    (a) On
      the
      terms and subject to the conditions of this Agreement, at the Closing referred
      to in Section
      2.1
      hereof,
      Company shall sell, convey, assign, transfer and deliver to Launch, and Launch
      shall purchase, acquire and accept delivery of Four Million (4,000,000) duly
      authorized, validly issued, fully paid and nonassessable shares of Common Stock,
      par value $.001 per share, of the Company free and clear of all liens and
      encumbrances imposed by Company other than restrictions on transfer as set
      forth
      in this Agreement (the “Shares”).

    

    (b)To
      effect
      the transfer contemplated by Section
      1.1(a),
      at the
      Closing, the Company shall deliver or cause to be delivered to Launch, against
      the payment therefore in accordance with Section
      1.2
      hereof,
      a stock certificate(s) for 4,000,000 shares of Common Stock of the Company
      (each
      a “Certificate”)
      representing the Shares.

      

    1.2 Purchase
      Price and Security. 

    

    (a)
      As
      payment for the Shares being acquired by Launch hereunder, Launch shall pay
      to
      Company $0.02 per share of common stock for a total sum of Eighty Thousand
      Dollars ($80,000.00) (the “Purchase
      Price”)
      which
      shall be payable in cash or certified funds at the Closing. 

     

    
      
        
          
             

          

          
            Securities
              Purchase Agreement

            BioAuthorize
              Holdings, Inc.

          

        

        
          Page
            1

          
            

          

        

        
          
          

          Execution
            Copy 

        

      

    

    SECTION
      2

    

    CLOSING
      AND THE PRE-CLOSING PERIOD

    

    2.1 Closing.
      The
      closing of the purchase and sale of the Shares pursuant to this Agreement (the
      "Closing")
      shall
      be on September 3, 2008 at 12:00 p.m. (the "Closing
      Date")
      and
      shall occur at the offices of the
      Company, 15849 N. 71st
      Street,
      Suite 226, Scottsdale, AZ 85254,
      or at
      such other time and place as shall be mutually agreed to by the
      Parties.

    

    At
      the
      Closing:

    

    (a) Company
      shall deliver the Certificates representing the Shares to Launch with
      instructions directing the transfer agent to register the Shares to Launch
      on
      the books of the Company and a certificate executed by Company to the effect
      that the conditions set forth in Section 6.2 have been satisfied;  

    

    (b) Launch
      shall deliver to Company that same day immediately available funds or a
      cashier's or certified check for $80,000.00; and

    

    (c) A
      certificate executed by Launch to the effect that the conditions set forth
      in
      Section 6.1 have been satisfied. 

    

    (d) The
      delivery of certificates of good standing by the Company and Launch dated within
      five (5) days of the Closing. 

     

    2.2 Termination
      in Absence of Closing.

     

    (a)
      Subject
      to the provisions of Section 6, if by the close of business on September 5,
      2008, the Closing has not occurred, then any Party hereto may thereafter
      terminate this Agreement by written notice to such effect, to the other Parties
      hereto, without liability of or to any party to this Agreement or any
      representative of such Party unless the reason for Closing having not occurred
      is (i) such Party’s willful breach of the provisions of this Agreement, or (ii)
      if all of the conditions to such Party’s obligations set forth in Section 6 have
      been satisfied or waived in writing by the date scheduled for the Closing
      pursuant to Section 2.1, the failure of such Party to perform its obligations
      under Section 2 on such date; provided,
      however,
      that
      the provisions of Sections 7.1 through 7.5 and Section 8.1 shall survive any
      such termination; and
      provided further, however,
      that
      any termination pursuant to this Section 2.2 shall not relieve any party hereto
      who was responsible for Closing having not occurred as described in clauses
      (i)
      or (ii) above of any liability for (x) such Party’s willful breach of the
      provisions of this Agreement, or (y) if all of the conditions to such Party’s
      obligations set forth in Section 6 have been satisfied or waived in writing
      by
      the date scheduled for the Closing pursuant to Section 2.1, the failure of
      such
      Party to perform its obligations under this Section 2 on such date.

     

    (b) This
      Agreement and the transactions contemplated herein may be terminated and
      abandoned at any time on or prior to the Closing Date by Launch if:

     

    
      
        
          
            
              
                 

              

              
                Securities
                  Purchase Agreement

                BioAuthorize
                  Holdings, Inc.

              

            

            
              Page
                2

              
                

              

            

            
              
              

              Execution
                Copy 

            

          

        

      

    

    1.  any
      representation or warranty made herein for the benefit of Launch, or any
      certificate, schedule or document furnished to Launch pursuant to this Agreement
      is untrue in any material respect; or

     

    2.  The
      Company shall have defaulted in any material respect in the performance of
      any
      material obligation under this Agreement.

     

    (c)
      This
      Agreement and the transactions contemplated herein may be terminated and
      abandoned at any time on or prior to the Closing Date by Company
      if:

     

    1. any
      representation or warranty made herein for the benefit of Company, or any
      certificate, schedule or document furnished to Company pursuant to this
      Agreement is untrue in any material respect; or 

     

    2.  Launch
      shall have defaulted in any material respect in the performance of any material
      obligation under this Agreement.

     

    THE
      PRE-CLOSING PERIOD

    

    2.3 Due
      Diligence, Delivery of Information, Inspection.
      During
      the period of time prior to the Closing of this Agreement (the "Pre-Closing
      Period"),
      Company shall make available to Launch
      for
      review and inspection the Company’s business, its assets and all materials,
      documentation and other information relating to the Company’s business, its
      assets and all other transactions contemplated by this Agreement (the
“Due
      Diligence”).
      

    

    (a) For
      many
      months and weeks prior to the Effective Date (the “Due
      Diligence Period”),
      Launch
      was
      given the opportunity to investigate, make its own independent evaluation of
      the
      Company’s business, financial condition and the risks associated with purchasing
      the Shares, and any and all other matters which Launch determined to be relevant
      to its decision to purchase the Shares (the “Investigation”).
      From
      the Investigation, Launch
      did not
      find any item for which it disapproved or which in any way deterred Launch’s
      desire to close the purchase of the Shares, or if it did so find any item of
      disapproval or deterrence, such item was corrected by the Company to Launch’s
      satisfaction prior to the Closing. Launch acknowledges that the Investigation
      was completed to its satisfaction.

     

     

    SECTION
      3

    

    REPRESENTATIONS
      AND WARRANTIES OF COMPANY

    

    Company
      hereby represents and warrants to Launch that:

     

    3.1 Corporate
      Existence and Qualification.
      Company
      is a corporation duly organized, validly existing and in good standing under
      the
      laws of the State of Nevada; Company has the corporate power to own, manage,
      lease and hold its properties and to carry on its business as and where such
      properties are presently located and such business is presently
      conducted.

     

    3.2 Authority,
      Approval and Enforceability.
      Company
      has all right, title and interest in and to the Shares and has the authority
      to
      sell, convey, assign, transfer and deliver to Launch the Shares free and clear
      of any and all liens, mortgages, adverse claims, charges, security interests,
      encumbrances or other restrictions or limitations whatsoever. This Agreement
      has
      been duly executed and delivered by Company and Company, respectively, and
      Company and Company each have all requisite power and legal capacity to execute
      and deliver this Agreement and all collateral agreements executed and delivered
      or to be executed and delivered in connection with the transactions provided
      for
      hereby, to consummate the transactions contemplated hereby and by the collateral
      agreements, and to perform their respective obligations hereunder and under
      the
      collateral agreements. This Agreement and each collateral agreement to which
      Company and Company are a party constitute, or upon execution and delivery
      will
      constitute, the legal, valid and binding obligation of such Party, enforceable
      in accordance with its terms, except as such enforcement may be limited by
      general equitable principles or by applicable bankruptcy, insolvency,
      moratorium, or similar laws and judicial decisions from time to time in effect
      which affect creditors’ rights generally. 

     

    
      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              3

            
              

            

          

          
            
            

            Execution
              Copy 

          

        

      

       

    

    3.3
      Capitalization
      and Corporate Records.

     

    (a)
      Company’s
      authorized capital stock consists of 100,000,000 shares of Common Stock, par
      value $.001 per share, and 1,000,000 shares of Preferred Stock, par value $.001
      per share, to be issued in series or classes as the Board of Directors shall
      determine, of which 23,725,000 shares of Common Stock are issued and
      outstanding. All of the outstanding shares of Company are duly authorized,
      validly issued, fully paid and non-assessable and were not issued in violation
      of (i) any preemptive or other rights of any person to acquire securities of
      Company, or (ii) any applicable federal or state securities laws, and the rules
      and regulations promulgated thereunder (collectively, the “Securities
      Laws”).
      There
      are no outstanding subscriptions, options, convertible securities, rights
      (preemptive or otherwise), warrants, calls or agreements relating to any shares
      of capital stock of Company. Upon delivery to Launch at the Closing of
      Certificates representing the Shares, good and valid title to the Shares will
      pass to Launch, free and clear of all liens, mortgages, adverse claims, charges,
      security interests, encumbrances or other restrictions or limitations
      whatsoever, other than those arising from acts of Launch.

     

    (b) The
      copies of the Articles of Incorporation and Bylaws of Company and the Report
      on
      Form 10-KSB for the year ended 12/31/07 and the Reports on Form 10-Q for the
      quarterly periods ending 3/31/08 and 6/30/08 provided to Launch al are true,
      accurate, and complete and reflect all amendments, where applicable, made
      through the date of this Agreement. Company’s stock and minute books made
      available to Launch for review were correct and complete as of the date of
      such
      review, no further entries have been made through the date of this Agreement,
      and such minute books contain an accurate record of all required stockholder
      and
      required corporate actions of the stockholders and directors (and any committees
      thereof) of Company taken by written consent or at a meeting. All corporate
      actions taken by Company have been duly authorized or ratified. All accounts,
      books, ledgers and official and other records of Company fairly and accurately
      reflect all of Company’s transactions, properties, assets and
      liabilities.

     

    3.4 No
      Company Defaults or Consents.
      The
      execution and delivery of this Agreement by Company and the performance by
      Company of its obligations hereunder will not violate any provision of law
      or
      any judgment, award or decree or any indenture, agreement or other instrument
      to
      which Company is a party, or by which the properties or assets of Company are
      bound or affected, or conflict with, result in a breach of or constitute (with
      due notice or lapse of time or both) a default under, any such indenture,
      agreement or other instrument, in each case except to the extent that such
      violation, default or breach could not reasonably be expected to delay or
      otherwise significantly impair the ability of the parties to consummate the
      transactions contemplated hereby.

    
       

      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              4

            
              

            

          

          
            
            

            Execution
              Copy 

          

        

      

       

    

    3.5 Litigation.
      As
      of the
      Closing, Company is unaware of any litigation filed against Company and has
      not
      received notification of any alleged facts which may give rise to any threatened
      litigation which would have a material adverse effect on Company.

     

    3.6 Brokers
      or Finders.
      Company
      has not incurred or will not incur, directly or indirectly, any liability for
      brokerage or finders’ fees or agents’ commissions or any similar charges in
      connection with this Agreement or any transaction contemplated
      hereby.

     

    SECTION
      4

    

    REPRESENTATIONS
      AND WARRANTIES OF LAUNCH

    

    Launch
      hereby represents and warrants to Company that:

    

    4.1
      Corporate
      Existence and Qualification; Authority, Approval and
      Enforceability.
      Launch
      is a corporation duly organized, validly existing and in good standing under
      the
      laws of the State of Arizona; Launch has the corporate power to own, manage,
      lease and hold its properties and to carry on its business as and where such
      properties are presently located and such business is presently conducted.
      This
      Agreement has been duly executed and delivered by Launch, and Launch has all
      requisite legal capacity to execute and deliver this Agreement and all
      collateral agreements executed and delivered or to be executed and delivered
      by
      Launch in connection with the transactions provided for hereby, to consummate
      the transactions contemplated hereby, and to perform its obligations hereunder.
      This Agreement to which Launch is a party constitutes, or upon execution and
      delivery will constitute, the legal, valid and binding obligation of Launch,
      enforceable in accordance with its terms, except as such enforcement may be
      limited by general equitable principles or by applicable bankruptcy, insolvency,
      moratorium, or similar laws and judicial decisions from time to time in effect
      which affect creditors’ rights generally.

     

    4.2
      No
      Default or Consents.
      Neither
      the execution and delivery of this Agreement nor the carrying out of the
      transactions contemplated hereby will:

     

    (a)  violate
      any legal requirements applicable to Launch; 

     

    (b)
      violate, conflict with, result in a breach of, constitute a default under
      (whether with or without notice or the lapse of time or both), or accelerate
      or
      permit the acceleration of the performance required by, or give any other party
      the right to terminate, any contract or permit applicable to Launch;

     

    (c)
      result in the creation of any lien, charge or other encumbrance on any property
      of Launch; or

     

    (d)
      require Launch to obtain or make any waiver, consent, action, approval or
      authorization of, or registration, declaration, notice or filing with, any
      private non-governmental third party or any governmental authority.

     

    4.3 No
      Proceedings.
      No
      suit, action or other proceeding is pending or, to Launch’s knowledge,
      threatened before any governmental authority seeking to restrain Launch or
      prohibit its entry into this Agreement or prohibit the Closing, or seeking
      damages against Launch or its properties as a result of the consummation of
      this
      Agreement.

    
       

      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              5

            
              

            

          

          
            
            

            Execution
              Copy 

          

        

      

    

     

    4.4
      Investment
      Representations.
      

     

    (a)
      Investment
      Intent.
      As a
      condition to the Company issuing the Shares to Launch, Launch represents and
      warrants as follows:

    

    (i)
      Respecting the Company, its business, plans and financial condition, and any
      other matters relating to issuance of the Shares: Launch has received all
      materials which have been requested by Launch including copies of the most
      recent report filed by the Company with the Securities and Exchange Commission
      on Form 10-Q for the quarterly periods ended March 31, 2008 and June 30, 2008
      and Form 10-KSB for the year ending December 31, 2007; has had a reasonable
      opportunity to ask questions of the Company and its representatives; and the
      Company has answered all inquiries that Launch or Launch's representatives
      have
      put to it. The Company undertakes no obligation to update, review or revise
      any
      forward-looking statements to reflect
      any change in the Company's expectations or any change in events, conditions,
      circumstances or assumptions on which any such statements are based. Launch
      has
      had access to all additional information necessary to verify the accuracy of
      the
      information set forth in this Agreement and any other materials furnished
      herewith, and has taken all the steps necessary to evaluate the merits and
      risks
      of an investment as proposed hereunder. 

    
      	
               

            	 	
              (ii)
                Launch is experienced in evaluating and investing in newly organized
                technology companies such as the Company. Launch has such knowledge
                and
                experience in financial and business matters to enable Launch to
                evaluate
                the merits and risks of
                an investment in the Shares, to make an informed investment decision
                with
                respect thereto, and
                can afford to bear such risks, including, without limitation, the
                risks of
                losing its entire investment in the Shares or if Launch were to purchase
                shares of Common Stock upon exercise of the Shares.
                

            

    

    
      	
               

            	 	
              (iii)
                Launch
                acknowledges, agrees and recognizes that neither the Company nor
                any of
                its affiliates or agents or consultants have made any representation
                or
                warranty concerning the Company's financial results, upon which Launch
                is
                relying in accepting the issuance of the Shares. Launch is subscribing
                for
                the Shares based solely upon Launch's own independent analysis of
                the
                Company's business and the historical financial information which
                is
                publicly available.

            

    

    
      	
               

            	 	
              (iv)
                Launch is aware that the Shares have not been registered under the
                Securities Act of 1933 (the “Act”),
                that
                the Shares will be issued on the basis of the statutory exemption
                provided
                by Section 4(2) of the Act or Regulation D promulgated thereunder,
                or
                both, relating to transactions by an issuer not involving any public
                offering and under similar exemptions under certain state securities
                laws,
                that this transaction has not been reviewed by, passed on or submitted
                to
                any Federal or state agency or self-regulatory organization where
                an
                exemption is being relied upon, and that the Company's reliance thereon
                is
                based in part upon the representations made by Launch in this Agreement.
                Launch acknowledges that Launch has been informed by the Company,
                or is
                otherwise familiar with, the nature of the limitations imposed by
                the Act
                (and applicable state securities laws) and the rules and regulations
                thereunder on the transfer of securities. In particular, Launch agrees
                that no sale, assignment or transfer of any of the Shares shall be
                valid
                or effective, and the Company shall not be required to give any effect
                to
                such sale, assignment or transfer, unless (i) such sale, assignment
                or
                transfer is registered under the Act (and applicable state securities
                laws), it being understood that the Shares are not currently registered
                for sale and that the Company has no obligation or intention to so
                register the Shares, except as contemplated hereunder or (ii) the
                Shares
                is sold, assigned or transferred in accordance with all the requirements
                and limitations of Rule 144 under the Act, it being understood that
                Rule
                144 is not available at the present time for the sale of the Shares,
                or
                (iii) such sale, assignment or transfer is otherwise exempt from
                the
                registration under the Act (and applicable state securities laws).
                Launch
                further understands that an opinion of counsel and other documents
                may be
                required to transfer the Shares. Launch acknowledges that the certificates
                evidencing the Shares shall bear the following, or a substantially
                similar
                legend, and such other legends as may be required by state blue-sky
                laws:
                

            

    

    
    

    
       

      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              6

            
              

            

          

          
            
            

            Execution
              Copy 

          

        

      
 

    
      	
               

            	 	
              "The
                securities represented by this certificate have not been registered
                under
                the Securities Act of 1933, or any state securities laws and neither
                such
                securities nor any interest therein may be offered, sold, pledged,
                assigned or otherwise transferred unless (1) a registration statement
                with
                respect thereto is effective under the Act and any applicable state
                securities laws, or (2) the Company receives an opinion of counsel
                to the
                holder of such securities, which counsel and opinion are reasonably
                satisfactory to the Company, that such securities may be offered,
                sold,
                pledged, assigned or transferred in the manner contemplated without
                an
                effective registration statement under the Act or applicable state
                securities laws." 

            

    

    (v)
      Launch is acquiring the Shares for investment for its own account and not with
      the view to, or for resale in connection with, any distribution thereof
or
      the
      granting of any participation therein, and has no present intention of
      distributing or selling to others any of such interest or granting
      participations therein. 

    (vi)
      Launch acknowledges that a limited trading market for the Shares presently
      exist
      and it is uncertain that a more active market for the Shares will develop in
      the
      future, and that Launch may find it impossible to liquidate the investment
      at a
      time when it may be desirable to do so, or at any other time. 

    
      	
               

            	 	
              (vii)
                Launch is not subscribing for the Shares because of or following
                any
                advertisement, article, notice or other communication published in
                any
                newspaper, magazine or internet site or similar media or broadcast
                over
                television or radio, or presented at any seminar or meeting, or any
                solicitation or a subscription by a person other than a representative
                of
                the Company. 

            

    

    
      	
               

            	 	
              (viii)
                Launch is not relying on the Company with respect to the tax and
                other
                economic considerations of an investment in the Shares.
                

            

    

    
      	
               

            	 	
              (ix)
                There are no registration rights for the
                Shares.

            

    

    (x)
      Without limiting the effect of any representation or warranty made by Company
      or
      Company, Launch and/or her agents have met with representatives of Company
      and
      Company and thereby have had the opportunity to ask questions of, and receive
      answers satisfactory to Launch concerning Company, the Shares and the terms
      and
      conditions of this transaction, as well as to obtain any information requested
      by Launch including, but not limited to information meeting the requirements
      of
      Rule 502(b) of Regulation D promulgated under the Act, and Launch further
      confirms that all documents requested by her have been and remain available
      for
      inspection or copying and that Launch has been supplied with all of the
      additional information concerning this investment that has been requested and
      has obtained other information necessary to verify the accuracy of the
      information given to it.

    
       

      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              7

            
              

            

          

          
            
            

            Execution
              Copy 

          

        

      

       

    

     (xi)
      Funds provided to Company by Launch are the exclusive property of Launch and
      have not been obtained by Launch’s issuance of any securities in violation of
      any federal or state securities laws. If any of the funds provide to Company
      by
      Launch have been obtained from the resources of any person other than Launch,
      such person is an “accredited investor” as that term is defined in Regulation D
      promulgated under the Act and Launch has obtained such funds only after
      disclosure of all material facts regarding Company, it business, properties
      and
      financial condition and of Launch to such person so that the person meets all
      of
      the qualifications and requirements in this Section 4.4.

     (xii)
      Launch acknowledges that the representations, warranties and agreements made
      by
      Launch herein shall survive the execution and delivery of this
      Agreement.

     

    (b)
      Purchaser
      Qualifications.
      Launch
has
      reviewed, understands and satisfies the eligible purchaser requirements under
      this Agreement as set forth in Rule 501(a) of Regulation D promulgated under
      the
      Act in that Launch at the time Launch was offered the Shares, it was, and as
      of
      the date of this Agreement and as of the Closing Date, will be an “accredited
      investor” as qualified under at least one of the categories set forth in Rule
      501(a), and Launch acknowledges that Company and Company have relied on Launch’s
      representation to form a reasonable belief that the Launch satisfies the
      eligible purchaser requirements set forth herein.

     

    SECTION
      5

     

    OBLIGATIONS
      PRIOR TO THE CLOSING

     

    5.1 Covenants
      of the Parties.
      Company
      and Launch covenant as follows:

    

    (a)
      From
      the
      Effective Date through the Closing, each Party shall promptly inform the other
      Parties in writing of any change in facts and circumstances that could render
      any of the representations and warranties made herein by the Party providing
      the
      notice, inaccurate or misleading if such representations and warranties had
      been
      made upon the occurrence of the fact or circumstance in question. 

     

    (b) From
      the
      Effective Date through the Closing, Company shall carry on the operation of
      its
      business in the ordinary course consistent with the practice conducted
      immediately prior to the Effective Date,
      and will
      use commercially reasonable efforts not to take any action inconsistent with
      this Agreement. Except as contemplated hereby or as may be incidental to or
      in
      furtherance of the transactions contemplated hereby or as may have been set
      forth herein, Company shall use commercially reasonable efforts to maintain
      the
      present character and quality of its business, including its present operations,
      physical facilities, working conditions, and relationships with lessors,
      licensors, suppliers, customers,
      partners
      (including, without limitation, joint venture partners, syndication partners
      and
      strategic partners)
      and
      employees. Without limiting the generality of the foregoing, unless consented
      to
      by Launch in writing, Company, except as specifically contemplated by this
      Agreement, shall not:

    
       

      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              8

            
              

            

          

          
            
            

            Execution
              Copy 

          

        

      

    

     

    (i) incur
      any
      indebtedness for borrowed or purchase money or letters of credit, or assume,
      guarantee, endorse (other than endorsements for deposit or collection in the
      ordinary course of business), or otherwise become responsible for obligations
      of
      any other person or entity except in the ordinary course of
      business;

     

    (ii) issue
      or
      redeem any securities other
      than
      pursuant to the exercise of options or warrants outstanding as of the date
      hereof;
      

     

    (iii) make
      or
      incur any obligation to make any distribution to its stockholders;

     

    (iv) make
      any
      change to its Articles of Incorporation or Bylaws; 

     

    (v) mortgage,
      pledge or otherwise encumber any of its assets or sell, transfer or otherwise
      dispose of any of its assets except in the ordinary course of
      business;

     

    (vi) make
      any
      investment of a capital nature either by purchase of stock or securities,
      contributions to capital, property transfer or otherwise, or by the purchase
      of
      any property or assets of any other person or entity, except in the ordinary
      course of business;

     

    (vii) adopt
      a
      plan of complete or partial liquidation, dissolution, merger, consolidation,
      restructuring, recapitalization or other reorganization or otherwise permit
      its
      corporate existence to be suspended, lapsed or revoked;

     

    (viii) sell,
      lease, license, transfer or otherwise dispose of assets of Company in excess
      of
      $10,000.00 in any single transaction or series of transactions;

     

    (ix) terminate
      any material contract or make any change in any material contract which will
      result in an aggregate value, cost or amount in excess of $50,000.00;

     

    (x) make
      any
      change in any method of accounting or accounting practice except as required
      by
      GAAP or applicable law;

     

    (xi) enter
      into, modify or amend any employment agreement or arrangement with, or grant
      any
      bonuses, salary increase, or retention pay to, any officer, director, consultant
      or key employee, other than (x) in connection with promotions or other changes
      in positions or responsibilities of employees that do not involve an increase
      in
      compensation, severance or benefits; or (y)  as may be required by
      applicable law or any benefit plan as in effect on the date hereof;

     

    (xii) modify,
      amend or terminate any benefit plan or increase the benefits provided under
      any
      benefit plan except as required by applicable law and except for implementation
      of the new health insurance plan of which Launch has provided assistance in
      sourcing and is fully aware and hereby acknowledges;

    
       

      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              9

            
              

            

          

          
            
            

            Execution
              Copy 

          

        

      

    

    (xiii) enter
      into, renew on materially different terms or agree to enter into, or renew
      on
      materially different terms, any employee welfare, pension, retirement,
      profit-sharing or similar plan, program, agreement, policy or arrangement except
      as required by applicable law;

     

    (xiv) enter
      into any new or renew any other material contract with respect to the Business
      which has an aggregate value, cost or amount in excess of
      $10,000.00;

     

    (xv) file
      any
      amended returns with respect to taxes, make
      or
      change any election in respect of material taxes, enter into any closing
      agreement, settle any claim or assessment in respect of material taxes, or
      consent to any extension or waiver of the limitation period applicable to any
      claim or assessment in respect of material taxes;

     

    (xvi) make
      any
      prepayments with respect to, or advance any funds under, any agreement or
      arrangement to which the Company is a party other than in the ordinary course
      of
      business; or

     

    (xvii) make
      any
      individual cash payment in excess of $10,000.00, other than payments made in
      the
      ordinary course of business (including, without limitation, payments for taxes
      due and payments to Company’s suppliers).

     

    SECTION
      6

     

    CONDITIONS
      TO Company’S AND LAUNCH’S OBLIGATIONS

     

    6.1 Conditions
      to Obligations of Company.
      The
      obligations of Company to sell the Shares are subject, at the option of Company,
      to the satisfaction or waiver by Company of the following
      conditions:

     

    (a)  All
      representations and warranties of Launch contained in this Agreement shall
      be
      true and correct in all material respects at and as of the Closing, and Launch
      shall have performed and satisfied in all material respects all covenants and
      agreements required by this Agreement to be performed and satisfied by Launch
      at
      or prior to the Closing.

     

    (b)  As
      of the
      Closing Date, no suit, action or other proceeding (excluding any such matter
      initiated by or on behalf of Company) shall be pending or threatened before
      any
      governmental authority seeking to restrain Company or prohibit the Closing
      or
      seeking damages against Company as a result of the consummation of this
      Agreement.

     

    (c)   All
      proceedings to be taken by Launch in connection with the transactions
      contemplated hereby and all documents incident thereto, including deliveries
      by
      Launch at the Closing under Section 2.1, shall be satisfactory in form and
      substance to Company and its counsel, and Company and said counsel shall have
      received all such counterpart originals or certified or other copies of such
      documents as it or they may reasonably request.

    
       

      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              10

            
              

            

          

          
            
            

            Execution
              Copy 

          

        

      

       

    

    (d) No
      proceeding in which Launch shall be a debtor, defendant or party seeking an
      order for its own relief or reorganization shall have been brought or be pending
      by or against Launch under any United States or state bankruptcy or insolvency
      law.

     

    6.2
      Conditions
      to Obligations of Launch.
      The
      obligations of Launch to purchase the Shares are subject, at the option of
      Launch, to the satisfaction, or waiver by Launch, of the following
      conditions:

    

    (a)
      All
      representations and warranties of Company contained in this Agreement shall
      be
      true and correct in all material respects at and as of the Closing, and Company
      shall have performed and satisfied in all material respects all agreements
      and
      covenants required by this Agreement to be performed and satisfied by them
      at or
      prior to the Closing.

    

    (b)
      As
      of the
      Closing Date, no suit, action or other proceeding (excluding any such matter
      initiated by or on behalf of Launch) shall be pending or threatened before
      any
      court or governmental agency seeking to restrain Launch or prohibit the Closing
      or seeking damages against Launch or Company or its properties as a result
      of
      the consummation of this Agreement. 

    (c)
      All
      proceedings to be taken by Company in connection with the transactions
      contemplated hereby and all documents incident thereto, including deliveries
      by
      Company at the Closing under Section 2.1, shall be satisfactory in form and
      substance to Launch and its counsel, and Launch and said counsel shall have
      received all such counterpart originals or certified or other copies of such
      documents as it or they may reasonably request.

    (d)
      No
      proceeding in which Company shall be a debtor, defendant or party seeking an
      order for its own relief or reorganization shall have been brought or be pending
      by or against Company under any United States or state bankruptcy or insolvency
      law.

    

    SECTION
      7

    

    POST-CLOSING
      OBLIGATIONS

    

    7.1
      Post-Closing
      Indemnification. 

     

    (a)
      Subject to the provisions of Section 8.1, from and after the Closing, Company
      and Company shall indemnify and hold harmless Launch for, from and against
      any
      and all damages arising out of, resulting from or in any way related to a breach
      of, or the failure to perform or satisfy any of, the representations,
      warranties, covenants and agreements made by Company or Company, respectively,
      in this Agreement or in any document or certificate delivered by Company or
      Company at the Closing pursuant hereto.

     

    (b)
      Subject to the provisions of Section 8.1, from and after the Closing, Launch
      shall indemnify and hold harmless Company for, from and against any and all
      damages arising out of, resulting from or in any way related to a breach of,
      or
      the failure to perform or satisfy any of, the representations, warranties,
      covenants and agreements and the obligations made by Launch in this Agreement
      or
      in any document or certificate delivered by Launch at the Closing pursuant
      hereto.

    
       

      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              11

            
              

            

          

          
            
            

            Execution
              Copy 

          

        

      

       

    

    7.2
      Anti-Piracy. During
      the
      Time Period, Launch shall not solicit or divert to a third party any business,
      contract, client, or prospective client that Launch learned of as a result
      of
      its relationship with Company, or assist any other person, firm, corporation,
      or
      entity in doing so or attempting to do so, nor will Launch use any information
      it receives regarding the business of Company, nor will Launch divulge such
      information to anyone, whether or not such information is confidential or
      propriety information of Company. Such information includes but is not limited
      to, clients and identified business opportunities (including identities,
      contacts, and requirements); financial information; the business of Company
      and
      marketing plans and strategies; and product formulas and
      ingredients.“Time
      Period”
      shall
      mean the period beginning as of the Closing Date of this Agreement and ending
      two (2) years after the Closing Date; provided
      however,
      that if
      a court of competent jurisdiction determines that such period is unenforceable,
      “Time
      Period”
      shall
      mean the period beginning as of the Closing Date and ending one (1) year after
      the Closing Date of this Agreement.

    

    7.3 Nonpublic
      Information. Except
      with respect to the material terms and conditions of the transactions
      contemplated by this Agreement, Company covenants and agrees that neither it,
      nor any other person acting on its behalf, will provide Launch or its agents
      or
      counsel with any information that the Company believes constitutes material
      non-public information, unless prior thereto Launch shall have executed a
      written agreement regarding the confidentiality and use of such information.
      Company understands and confirms that Launch shall be relying on the foregoing
      covenant in effecting transactions in securities of Company.

    

    7.4 Form
      D; Blue Sky Filings.
      The
      Company agrees to timely file a Form D with respect to the Securities as
      required under Regulation D and to provide a copy thereof, promptly upon request
      of any Purchaser. The Company shall take such action as the Company shall
      reasonably determine is necessary in order to obtain an exemption for, or to
      qualify the Securities for, sale to the Purchasers at the Closing under
      applicable securities or “Blue Sky” laws of the states of the United States, and
      shall provide evidence of such actions promptly upon request of any
      Purchaser.

     

    7.5 Securities
      Laws Disclosure; Publicity.
      Company
      shall, within 4 business days following the Closing Date, issue a Current Report
      on Form 8-K, disclosing the material terms of the transactions contemplated
      hereby, and including the Agreement as an exhibit thereto. Company and Launch
      shall consult with each other in issuing any other press releases with respect
      to the transactions contemplated hereby, and neither Company nor Launch shall
      issue any such press release nor otherwise make any such public statement
      without the prior consent of Company, with respect to any press release of
      Launch, or without the prior consent of Launch, with respect to any press
      release of Company, which consent shall not unreasonably be withheld or delayed,
      except if such disclosure is required by law, in which case the disclosing
      party
      shall promptly provide the other party with prior notice of such public
      statement or communication. Notwithstanding the foregoing, Company shall not
      publicly disclose the name of Launch, or include the name of Launch in any
      filing with the Commission or any regulatory agency, without the prior written
      consent of Launch, except: (a) as required by federal securities law in
      connection with the filing of the final Agreement (including signature pages
      thereto) with the SEC and (b) to the extent such disclosure is required by
      law
      or applicable regulations, in which case Company shall provide Launch with
      prior
      notice of such disclosure permitted under this clause (b).

    
       

      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              12

            
              

            

          

          
            
            

            Execution
              Copy 

          

        

      

       

    

    SECTION
      8

    

    GENERAL
      PROVISIONS

    

    8.1
      Limitation
      on Liability.

     

    (a)
      The
      representations, warranties, agreements, and indemnities of Launch and Company
      set forth in this Agreement or in connection with the transactions contemplated
      hereby shall survive the Closing except as expressly provided in Section
      8.1(b).

     

    (b)
      No
      party shall have any liability under this Agreement to indemnify (collectively
      the “Business
      Indemnities”),
      in
      each case unless the indemnifying Party receives notice in writing from the
      other Party of such claim under said indemnity on or before the two-year
      anniversary of the Closing Date. The foregoing limitations shall not apply
      to
      claims under the Note or claims brought or arising under Section 3.3 and such
      representations, warranties and indemnification claims shall survive the Closing
      and shall expire upon the date of the expiration of the applicable statute
      of
      limitations. The foregoing limitations shall not apply to any breaches of or
      obligations to comply with any of the other provisions of this Agreement,
      regardless of whether such breach or obligation also constitutes a breach or
      obligation under any of the provisions specifically listed in this Section
      8.1(b).

     

    (c)
      For
      purposes of this Section 8.1(c), a Party making a claim for indemnity under
      Section 7.1 is hereinafter referred to as an “Indemnified
      Party”
      and the
      Party against whom such claim is asserted is hereinafter referred to as the
      “Indemnifying
      Party”.
      All
      claims by any Indemnified Party under Section 7.1 hereof shall be asserted
      and
      resolved in accordance with the following provisions. If any claim or demand
      for
      which an Indemnifying Party would be liable to an Indemnified Party is asserted
      against or sought to be collected from such Indemnified Party by a third party,
      said Indemnified Party shall with reasonable promptness notify in writing the
      Indemnifying Party of such claim or demand stating with reasonable specificity
      the circumstances of the Indemnified Party’s claim for indemnification;
provided,
      however,
      that any
      failure to give such notice will not waive any rights of the Indemnified Party
      except to the extent the rights of the Indemnifying Party are actually
      prejudiced or to the extent that any applicable period set forth in Section
      8.1(b) has expired without such notice being given. After receipt by the
      Indemnifying Party of such notice, then upon reasonable notice from the
      Indemnifying Party to the Indemnified Party, or upon the request of the
      Indemnified Party, the Indemnifying Party shall defend, manage and conduct
      any
      proceedings, negotiations or communications involving any claimant whose claim
      is the subject of the Indemnified Party’s notice to the Indemnifying Party as
      set forth above, and shall take all actions necessary, including but not limited
      to the posting of such bond or other security as may be required by any
      governmental authority, so as to enable the claim to be defended against or
      resolved without expense or other action by the Indemnified Party. Upon request
      of the Indemnifying Party, the Indemnified Party shall, to the extent it may
      legally do so and to the extent that it is compensated in advance by the
      Indemnifying Party for any costs and expenses thereby incurred,

     

    (i)
      take
      such action as the Indemnifying Party may reasonably request in connection
      with
      such action,

     

    a.  allow
      the
      Indemnifying Party to dispute such action in the name of the Indemnified Party
      and to conduct a defense to such action on behalf of the Indemnified Party,
      and

    
       

      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              13

            
              

            

          

          
            
            

            Execution
              Copy 

          

        

      

    

    b.  
      render
      to the Indemnifying Party all such assistance as the Indemnifying Party may
      reasonably request in connection with such dispute and defense.

     

    8.2 Final
      Agreement.
      This
      Agreement constitutes the final and complete agreement between the Parties
      concerning the subject matter of this Agreement. This Agreement supersedes
      all
      prior agreements, understandings, negotiations and discussions, written or
      oral,
      between the Parties with respect thereto. Any modification, revision or
      amendment of this Agreement shall not be effective unless made in a writing
      executed by the Parties.

    

    8.3 Language.
      The
      language used in this Agreement shall be deemed to be the language chosen by
      the
      Parties to express their mutual intent, and no rule of strict construction
      shall
      be applied against any Party.

    

    8.4 Severability.
      In case
      any one or more of the provisions contained herein shall, for any reason, be
      held to be invalid, illegal, or unenforceable in any respect, such invalidity,
      illegality or unenforceability shall not affect any other provisions of this
      Agreement, and this Agreement shall be construed as if the invalid, illegal
      or
      unenforceable provisions(s) had never been contained herein; provided that
      such
      invalid, illegal or unenforceable provisions shall first be curtailed, limited
      or eliminated to the extent necessary to remove such invalidity, illegality
      or
      unenforceability with respect to the applicable law as it shall then be
      applied.

    

    8.5 Waiver.
      Except
      as
      expressly set forth herein, any waiver of, or promise not to enforce, any right
      under this Agreement shall not be enforceable unless evidenced by a writing
      signed by the Party making such a waiver or promise.

    

    8.6 Headings.
      The
      headings in this Agreement are for the purpose of convenience only and shall
      not
      limit, enlarge or affect any of the covenants, terms, conditions or provisions
      of this Agreement.

    

    8.7 Effect
      of Recitals.
      The
      recitals contained in this Agreement are an integral part of this
      Agreement.

    

    8.8 Notices.
      All
      notices, requests, demands and other communications made pursuant to this
      Agreement shall be in writing and shall be sent by registered or certified
      mail,
      return receipt requested, or by commercial courier or by facsimile transmission
      to the Parties at the addresses or numbers set forth below, or to such other
      person and place as the Party shall designate by notice to the other
      Party:

    
       

      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              14

            
              

            

          

          
            
            

            Execution
              Copy 

          

        

      

    

     

    
      
        	 	
                Company:

              	
                BioAuthorize
                  Holdings, Inc.

              
	 	 	
                15849
                  N. 71st
                  Street, Suite 226

              
	 	 	
                Scottsdale,
                  AZ 85254

              
	 	 	 
	 	 	 
	 	
                Launch:

              	
                Launch
                  Pad Research and 

              
	 	 	
                Marketing
                  Company

              
	 	 	
                16680
                  N. 174th
                  Lane

              
	 	 	
                Surprise,
                  AZ 85388

              
	 	 	 
	 	
                With
                  copies to:

              	
                Jeffrey
                  R. Perry

              
	 	 	
                Jeffrey
                  R. Perry Law Firm, P.C.

              
	 	 	
                7119
                  E. Shea Blvd., Suite 109-111

              
	 	 	
                Scottsdale,
                  AZ 85254-6107

              
	 	 	 
	 	 	 
	 	 	
                ___________________________

              
	 	 	 

      

      
         

        
          
            
              
                 

              

              
                Securities
                  Purchase Agreement

                BioAuthorize
                  Holdings, Inc.

              

            

            
              Page
                15

              
                

              

            

            
              
              

              Execution
                Copy 

            

          

        

         

      

    

    8.9 Assignments.
      No Party
      may assign this Agreement or delegate any obligations under this Agreement
      without obtaining the written consent of each of the other Parties.

    

    8.10 Counterparts.
      This
      Agreement may be executed in any number of counterparts, each of which shall
      be
      deemed an original, but all of which taken together shall constitute one and
      the
      same instrument.

    

    8.11 Governing
      Law.
      This
      Agreement shall be governed construed and enforced in accordance with the laws
      of the State of Arizona and the laws of the United States of America.

    

    8.12  Remedies. 

    

    (a)
      Except as provided below, the parties agree to submit disputes between them
      relating to this Agreement and its formation, breach, performance,
      interpretation and application to arbitration. Arbitration will be conducted
      in
      Phoenix, Maricopa County, Arizona pursuant to the Rules of the American
      Arbitration Association (“AAA”),
      as
      modified herein. The arbitration shall be conducted by one (1) arbitrator chosen
      in accordance with the rules of the AAA. Unless the arbitrator finds that
      exceptional circumstances require otherwise, the arbitrator will grant the
      prevailing party in arbitration its costs of arbitration and reasonable
      attorneys’ fees as part of the arbitration award. Either party will be entitled
      to receive in any court of competent jurisdiction located within the State
      of
      Arizona injunctive, preliminary or other equitable relief, in addition to
      damages, including court costs and fees of attorneys and other professionals,
      to
      remedy any actual or threatened violation of its rights with respect to which
      arbitration is not required hereunder. In this regard and for the purposes
      of
      set forth above, the parties hereto irrevocably submit to the exclusive
      jurisdiction of any federal or state court located within the State of
      Arizona.

    

    (b)
      Each
      of the parties hereto agrees that a judgment in any such dispute may be enforced
      in Arizona or in other jurisdictions by suit for judgment on the arbitration
      award or in any other manner provided by law.

    (c)
      Each
      of the parties hereto hereby consents to process being served by any party
      to
      this Agreement in any suit, action or proceeding by the mailing of a copy
      thereof to the address of such party set forth above.

    

    (d)
      The
      parties agree that they will incur irreparable harm for any breach of the terms
      and conditions of this Agreement and that the remedy of damages shall be
      inadequate in such event. Therefore, the parties agree that the Company shall
      be
      entitled to equitable remedies in the event of any breach or threatened breach
      of the terms and conditions of this Agreement including, without limitation,
      the
      entry of an injunction to prevent or correct any such breach.

     

    [SIGNATURES
      ON FOLLOWING PAGE]

    
      
        Securities
          Purchase Agreement

        BioAuthorize
          Holdings, Inc.

         

        
        

      

      
        Page
          16

        
          

        

      

      
        
        

        Execution
          Copy 

      

    

    

    IN
      WITNESS WHEREOF, the Parties have executed this Securities Purchase Agreement
      as
      of the date first above written.

    

    Company:

    BioAuthorize
      Holdings, Inc.

    

    

    

    By:
/s/
      Yada Schneider

    

    Name:
      Yada Schneider

    

    Title:
      President & CEO

    

    Launch:

    Launch
      Pad Research and Marketing Company

    

    

    

    By:
/s/
      Doug Oberan

     

    Name:
      Doug Oberan

    

    Title:
      President

    
       

      
        
          
            
               

            

            
              Securities
                Purchase Agreement

              BioAuthorize
                Holdings, Inc.

            

          

          
            Page
              17

            
              

            

          

          
            
            

            Execution
              Copy

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]